What is the NOAEL for Dihydroergotamine mesylate?
Dihydroergotamine mesylate has 7 NOAEL studies in the database. The lowest reported value is developmental listing type. Source: California Proposition 65.
Also known as: Dihydroergotamine methanesulfonate, Dihydroergotamine methanesulfonate salt, Ergotamine, 9,10-dihydro-, monomethanesulfonate (salt), Ergotoman-3',6',18-trione,9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, monomethanesulfonate (salt)
CAS 6190-39-2
Dihydroergotamine mesylate (CAS 6190-39-2) is a chemical substance; key hazard signal: developmental. Key regulatory status: California Proposition 65, 1 regulatory/inventory list, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, CA Prop 65.
Dihydroergotamine mesylate is prohibited in EU cosmetics but has active industrial GHS classifications (H312, H332).
CAS, identifiers, formula, and alternate names for the matched substance record.
California OEHHA listing status and toxicity category.
| Chemical | Toxicity Type | Cancer | Developmental | Listed |
|---|---|---|---|---|
| - | developmental | No | Yes | - |
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| OEHHA Proposition 65 (1/2023) | California Office of Environmental Health Hazard Assessment | OEHHA Proposition 65 List |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| FRdevelopmental | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| FRdevelopmental | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| FRdevelopmental | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| 81AXN7R2QT | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 81AXN7R2QT | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 81AXN7R2QT | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 81AXN7R2QT | UNII | FDA UNII substance identifier | - | - | openFDA substances |
Showing 7 of 7 studies
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Dihydroergotamine mesylate has 7 NOAEL studies in the database. The lowest reported value is developmental listing type. Source: California Proposition 65.
Dihydroergotamine mesylate appears on 1 regulatory/inventory list including OEHHA Proposition 65 (1/2023). Source: EPA CPDat.
Yes, Dihydroergotamine mesylate is listed under California Proposition 65 for developmental. Source: California OEHHA Proposition 65.
Yes, Dihydroergotamine mesylate is also indexed as a cosmetic ingredient under the name Dihydroergotamine. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, EPA DSSTox, California Proposition 65, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Dihydroergotamine mesylate is prohibited in EU cosmetics but has active industrial GHS classifications (H312, H332).
Dihydroergotamine mesylate also appears in cosmetics, pharmaceutical databases.